RLYB 8-K 2026-11-06

Rallybio Corp (RLYB) 8-K dated 2026-11-06 — accession 0001193125-26-452115.

Rallybio Corp (RLYB) is a biotechnology company listed on US.

Rallybio Corp filed a 8-K on 2026-11-06. Accession 0001193125-26-452115.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported RLYB revenue for 2025-12-31 was $858.0K. Net income was -$9.0M. Revenue was up 43.0% from 2024-12-31 to 2025-12-31. RLYB currently screens at market cap $13.8M.

Not investment advice. The RLYB SEC hub lists recent forms. The stock page is the research view.